TRAZODONE TABLETS
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
Solicitation SPE2DP-27-T-0173 is a federal procurement issued by the DLA Troop Support Medical Supply Chain Pharm FSA for Trazodone Hydrochloride USP tablets. Each tablet must contain 50 mg of the active ingredient, with the unit of issue defined as a bottle containing 100 tablets. The requirement specifies a total shelf life of 24 months, with a minimum of 21 months remaining upon receipt by the first government activity. The product must be stored at a controlled room temperature between 20 and 25 degrees Celsius. The contract mandates strict adherence to FDA regulations and Medical Marking Standard No. 1, which supersedes MIL-STD-129. Required labeling includes the National Stock Number, manufacturer, date of manufacture, expiration or retest date, contract number, and lot number. Packaging must be commercial and consist of sealed unit containers within suitable exterior shipping containers. Delivery is required within 5 days after receipt of order, with a destination of Vilseck, Germany. Invoicing and payment must be processed electronically through the Wide Area WorkFlow system.
General Info
Place of Performance
DEUSet-Aside
Timeline
Response Deadline
Organization & Contact Information
Full Description
TRAZODONE TABLETS<(>,<)> USP
EACH TABLET CONTAINS: 50 MG TRAZODONE HYDROCHLORIDE, USP.
RX ONLY.
UNIT OF ISSUE IS A BOTTLE CONTAINING 100 TABLETS EACH
TOTAL SHELF LIFE IS 24 MONTHS. THERE SHALL BE A MINIMUM OF 21 MONTHS OF
TOTAL SHELF LIFE REMAINING AT THE TIME OF RECEIPT BY THE FIRST
GOVERNMENT ACTIVITY.
STORE AT 20° TO 25°C (68° TO 77°F) [SEE USP CONTROLLED ROOM
TEMPERATURE].
LABELING AND MARKING: MUST INCLUDE THE FOLLOWING: NATIONAL STOCK NUMBER,
MANUFACTURER, DATE OF MANUFACTURER, EXPIRATION DATE OR RETEST DATE,
CONTRACT NUMBER AND LOT NUMBER
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
SPE2DP-27-T-0173
SECTION B
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
APOTEX CORP. 4PX51 P/N NDC60505-2653-01 TEVA PHARMACEUTICALS USA, INC. 3V8D7 P/N NDC50111-0560-01
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7018847132 0001 BT 4.000
NSN/MATERIAL:6505011374627
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:A
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:Z PACKING LEVEL: B
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
SPE2DP-27-T-0173
SECTION B
PR: 7018847132 PRLI: 0001 CONT’D
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
INCLUDE IP025 OBJECT TEXT ID ST LANGUAGE E
BULK BREAK POINT:
WK4F8Q
W6Y1 USALRCTR BAVARIA
AWCF SSF 405TH AFSB EUR
ROSE BARRACKS SOUTH CAMP BLDG 113
VILSECK 92249
DE
FOR TRANSPORTATION SEE DLAD DLAD PROC NOTE C19. FOR FIRST DESTINATION TRANSPORTATION SEE DLAD PROC NOTE
C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
WK4F8Q
W6Y1 USALRCTR BAVARIA
AWCF SSF 405TH AFSB EUR
ROSE BARRACKS SOUTH CAMP BLDG 113
VILSECK 92249
DE
MARKFOR
WK4F8Q
W6Y1 USALRCTR BAVARIA
AWCF SSF 405TH AFSB EUR
ROSE BARRACKS SOUTH CAMP BLDG 113
VILSECK 92249
DE
M/F: (TCN) WK4F8Q62930212
RDD: 308
PROJ: TP 1
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 02
DIC: A01 DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:10/27/2026
SPE2DP-27-T-0173 NSN/Part Number: 6505-01-137-4627 Quantity: 4 BT Purchase Request: 7018847132QTY: 4 Delivery: 5 days ADO
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
